Sanofi - Aventis Groupe: Press Release: Nirsevimab: Sanofi,

Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of nirsevimab

Related Keywords

United States , Paris , France General , France , Sandrine Guendoul , Evan Berland , Tarik Elgoutni , Felix Lauscher , Corentine Driancourt , Eva Schaefer Jansen , Nathalie Pham , European Union , Euronext , Nasdaq , Astrazeneca , Collaboration Agreement , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , Sanofi , Eventis , Roupe , Dress , Release , Nirsevimab , Gobi , Simplify , Contractual , Agreements ,